3H-quinazolin-4-one derivatives as MAO-B inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S286000

Reexamination Certificate

active

07087612

ABSTRACT:
This invention relates to 3H-quinazolin-4-one derivatives as defined in the specification and claims, to a process for their preparation, to pharmaceutical compositions comprising them and to their use as selective monoamine oxidase B inhibitors.

REFERENCES:
patent: 4668682 (1987-05-01), Sekiya et al.
patent: 5783577 (1998-07-01), Houghten et al.
patent: 6890930 (2005-05-01), Mederski et al.
patent: WO 96/40095 (1996-12-01), None
patent: WO 97/33572 (1997-09-01), None
patent: WO 99 10349 (1999-03-01), None
patent: WO 01/34172 (2001-05-01), None
Bach et al., Proc. Natl. Acad. Sci. vol. 85: pp. 4934-4938 (1988).
Cesura & Pletscher, Prog. Drug Research vol. 38: pp. 171-297 (1992).
Fowler et al., J. Neural. Transm. vol. 49: pp. 1-20 (1980).
Benedetti et al., Biochem. Pharmacol. vol. 38: pp. 555-561 (1989).
Saura et al., Neuroscience vol. 70: pp. 755-774 (1996).
Bentué-Ferrer et al., CNS Drugs vol. 6: pp. 217-236 (1996).
Gardner et al. J. Clin. Psychiatry vol. 57: pp. 99-104 (1996).
Schlaeger & Christensen, Cytotechnology vol. 30: pp. 71-83 (1999).
Zhou & Panchuk-Voloshina, Analytical Biochemistry vol. 253: pp. 169-174 (1997).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3H-quinazolin-4-one derivatives as MAO-B inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3H-quinazolin-4-one derivatives as MAO-B inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3H-quinazolin-4-one derivatives as MAO-B inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3668350

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.